{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:00:44Z","timestamp":1792411244111,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cost Eff Resour Alloc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Breast cancer-related lymphedema (BCRL) imposes a significant economic burden on patients, providers, and society. There is no curative therapy for BCRL, but management through self-care can reduce symptoms and lower the risk of adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>The economic burden of BCRL stems from related adverse events, reductions in productivity and employment, and the burden placed on non-medical caregivers. Self-care regimens often include manual lymphatic drainage, compression garments, and meticulous skin care, and may incorporate pneumatic compression devices. These regimens can be effective in managing BCRL, but patients cite inconvenience and interference with daily activities as potential barriers to self-care adherence. As a result, adherence is generally poor and often worsens with time. Because self-care is on-going, poor adherence reduces the effectiveness of regimens and leads to costly treatment of BCRL complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Novel self-care solutions that are more convenient and that interfere less with daily activities could increase self-care adherence and ultimately reduce complication-related costs of BCRL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12962-023-00455-7","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T09:01:39Z","timestamp":1690621299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lymphedema self-care: economic cost savings and opportunities to improve adherence"],"prefix":"10.1186","volume":"21","author":[{"given":"Pinar","family":"Karaca-Mandic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Solid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Armer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Skoracki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Campione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley G.","family":"Rockson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"455_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/jco.2008.17.9291","volume":"27","author":"SA Norman","year":"2009","unstructured":"Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390\u20137. https:\/\/doi.org\/10.1200\/jco.2008.17.9291.","journal-title":"J Clin Oncol"},{"key":"455_CR2","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s00520-020-05890-3","volume":"29","author":"T De Vrieze","year":"2021","unstructured":"De Vrieze T, Gebruers N, Nevelsteen I, Tjalma WAA, Thomis S, De Groef A, Dams L, Haenen V, Devoogdt N. Breast cancer-related lymphedema and its treatment: how big is the financial impact? Support Care Cancer. 2021;29:3801\u201313. https:\/\/doi.org\/10.1007\/s00520-020-05890-3.","journal-title":"Support Care Cancer"},{"key":"455_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00520-019-05101-8","volume":"28","author":"T De Vrieze","year":"2020","unstructured":"De Vrieze T, Nevelsteen I, Thomis S, De Groef A, Tjalma WAA, Gebruers N, Devoogdt N. What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Support Care Cancer. 2020;28:439\u201349. https:\/\/doi.org\/10.1007\/s00520-019-05101-8.","journal-title":"Support Care Cancer"},{"key":"455_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjsurg.2015.06.015","volume":"211","author":"MN Basta","year":"2016","unstructured":"Basta MN, Fox JP, Kanchwala SK, Wu LC, Serletti JM, Kovach SJ, Fosnot J, Fischer JP. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211:133\u201341. https:\/\/doi.org\/10.1016\/j.amjsurg.2015.06.015.","journal-title":"Am J Surg"},{"key":"455_CR5","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007\u201314. https:\/\/doi.org\/10.1200\/JCO.2008.18.3517.","journal-title":"J Clin Oncol"},{"key":"455_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s40064-016-2300-8","volume":"5","author":"J Boyages","year":"2016","unstructured":"Boyages J, Kalfa S, Xu Y, Koelmeyer L, Mackie H, Viveros H, Taksa L, Gollan P. Worse and worse off: the impact of lymphedema on work and career after breast cancer. Springerplus. 2016;5:657. https:\/\/doi.org\/10.1186\/s40064-016-2300-8.","journal-title":"Springerplus"},{"key":"455_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.13189\/cor.2013.010203","volume":"1","author":"C Bulley","year":"2013","unstructured":"Bulley C, Coutts F, Blyth C, Jack W, Chetty U, Barber M, Tan CW. Prevalence and impacts of upper limb morbidity after treatment for breast cancer: a cross-sectional study of lymphedema and function. Cancer Oncol Res. 2013;1:30\u20139.","journal-title":"Cancer Oncol Res"},{"key":"455_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5152\/ejbh.2019.4385","volume":"15","author":"E Giray","year":"2019","unstructured":"Giray E, Aky\u00fcz G. Assessment of family caregiver burden and its relationships between quality of life, arm disability, grip strength, and lymphedema symptoms in women with postmastectomy lymphedema: a prospective cross-sectional study. Eur J Breast Health. 2019;15:111\u20138. https:\/\/doi.org\/10.5152\/ejbh.2019.4385.","journal-title":"Eur J Breast Health"},{"key":"455_CR9","first-page":"142","volume":"47","author":"HN Mayrovitz","year":"2014","unstructured":"Mayrovitz HN, Weingrad DN, Davey S. Tissue dielectric constant (TDC) measurements as a means of characterizing localized tissue water in arms of women with and without breast cancer treatment related lymphedema. Lymphology. 2014;47:142\u201350.","journal-title":"Lymphology"},{"key":"455_CR10","doi-asserted-by":"publisher","first-page":"e114597","DOI":"10.1371\/journal.pone.0114597","volume":"9","author":"KM Brayton","year":"2014","unstructured":"Brayton KM, Hirsch AT, B PJO, Cheville A, Karaca-Mandic P, Rockson SG. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS ONE. 2014;9:e114597. https:\/\/doi.org\/10.1371\/journal.pone.0114597.","journal-title":"PLoS ONE"},{"key":"455_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.avsg.2019.08.091","volume":"63","author":"SS Desai","year":"2020","unstructured":"Desai SS, Shao M, Vascular Outcomes C. Superior clinical, quality of life, functional, and health economic outcomes with pneumatic compression therapy for lymphedema. Ann Vasc Surg. 2020;63:298\u2013306. https:\/\/doi.org\/10.1016\/j.avsg.2019.08.091.","journal-title":"Ann Vasc Surg"},{"key":"455_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamadermatol.2015.1895","volume":"151","author":"P Karaca-Mandic","year":"2015","unstructured":"Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema. JAMA Dermatol. 2015;151:1187\u201393. https:\/\/doi.org\/10.1001\/jamadermatol.2015.1895.","journal-title":"JAMA Dermatol"},{"key":"455_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00520-013-1962-9","volume":"22","author":"JC Brown","year":"2014","unstructured":"Brown JC, Cheville AL, Tchou JC, Harris SR, Schmitz KH. Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer. 2014;22:135\u201343. https:\/\/doi.org\/10.1007\/s00520-013-1962-9.","journal-title":"Support Care Cancer"},{"key":"455_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/jpm5040370","volume":"5","author":"PL Ostby","year":"2015","unstructured":"Ostby PL, Armer JM. Complexities of adherence and post-cancer lymphedema management. J Pers Med. 2015;5:370\u201388. https:\/\/doi.org\/10.3390\/jpm5040370.","journal-title":"J Pers Med"},{"key":"455_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/lrb.2021.0091","volume":"20","author":"N Erdin\u00e7 G\u00fcnd\u00fcz","year":"2022","unstructured":"Erdin\u00e7 G\u00fcnd\u00fcz N, \u015eahin E, Dilek B, Ellidokuz H, Akal\u0131n E. Adherence to compression garment wear and associated factors among patients with breast cancer-related lymphedema: a pilot study from a Turkish tertiary center. Lymphat Res Biol. 2022;20:665\u201370. https:\/\/doi.org\/10.1089\/lrb.2021.0091.","journal-title":"Lymphat Res Biol"},{"key":"455_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00520-015-2766-x","volume":"24","author":"J Alcorso","year":"2016","unstructured":"Alcorso J, Sherman KA, Koelmeyer L, Mackie H, Boyages J. Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema. Support Care Cancer. 2016;24:139\u201346. https:\/\/doi.org\/10.1007\/s00520-015-2766-x.","journal-title":"Support Care Cancer"},{"key":"455_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.16495","author":"W Jiang","year":"2022","unstructured":"Jiang W, Chen L. Analysis of the factors and moderating role of self-care ability among patients with breast cancer-related lymphedema. J Clin Nurs. 2022. https:\/\/doi.org\/10.1111\/jocn.16495.","journal-title":"J Clin Nurs"},{"key":"455_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/PHM.0000000000000178","volume":"94","author":"JC Brown","year":"2015","unstructured":"Brown JC, Kumar A, Cheville AL, Tchou JC, Troxel AB, Harris SR, Schmitz KH. Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema. Am J Phys Med Rehabil. 2015;94:288\u201396. https:\/\/doi.org\/10.1097\/PHM.0000000000000178.","journal-title":"Am J Phys Med Rehabil"},{"key":"455_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06390-8","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu Y, Zhou C, Li W, Li X, Chen L. Breast cancer-related lymphedema patient and healthcare professional experiences in lymphedema self-management: a qualitative study. Support Care Cancer. 2021. https:\/\/doi.org\/10.1007\/s00520-021-06390-8.","journal-title":"Support Care Cancer"},{"key":"455_CR20","first-page":"191","volume":"164","author":"SR Harris","year":"2001","unstructured":"Harris SR, Hugi MR, Olivotto IA, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 11 lymphedema. CMAJ. 2001;164:191\u20139.","journal-title":"CMAJ"},{"key":"455_CR21","doi-asserted-by":"publisher","first-page":"151301","DOI":"10.1016\/j.apnr.2020.151301","volume":"54","author":"N Schreiner","year":"2020","unstructured":"Schreiner N, DiGennaro S, Harwell C, Burant C, Daly B, Douglas S. Treatment burden as a predictor of self-management adherence within the primary care population. Appl Nurs Res. 2020;54:151301. https:\/\/doi.org\/10.1016\/j.apnr.2020.151301.","journal-title":"Appl Nurs Res"},{"key":"455_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00520-010-0906-x","volume":"19","author":"S Vignes","year":"2011","unstructured":"Vignes S, Porcher R, Arrault M, Dupuy A. Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer. 2011;19:935\u201340. https:\/\/doi.org\/10.1007\/s00520-010-0906-x.","journal-title":"Support Care Cancer"},{"key":"455_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2022.06.016","author":"SG Rockson","year":"2022","unstructured":"Rockson SG, Whitworth PW, Cooper A, Kania S, Karnofel H, Nguyen M, Shadduck K, Gingerich P, Armer J. Safety and effectiveness of a novel non-pneumatic active compression device for treating breast cancer-related lymphedema, a multi-center randomized, crossover trial (NILE). J Vasc Surg Venous Lymphat Disord. 2022. https:\/\/doi.org\/10.1016\/j.jvsv.2022.06.016.","journal-title":"J Vasc Surg Venous Lymphat Disord"}],"container-title":["Cost Effectiveness and Resource Allocation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-023-00455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12962-023-00455-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-023-00455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T09:03:05Z","timestamp":1690621385000},"score":1,"resource":{"primary":{"URL":"https:\/\/resource-allocation.biomedcentral.com\/articles\/10.1186\/s12962-023-00455-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1186\/s12962-023-00455-7","relation":{},"ISSN":["1478-7547"],"issn-type":[{"value":"1478-7547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"13 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PKM serves as a paid advisor to Koya Medical, serves as a consultant to Mayo Clinic for unrelated work and holds an executive position and equity in Xanthos Health, which is developing health information technology applications in social drivers of health unrelated to this work. CAS serves as a paid consultant to Koya Medical. SGR serves as a paid medical advisor to Koya Medical. JMA serves as an unpaid research consultant to Koya Medical. RS serves as an unpaid advisor to Koya Medical. EC serves as an unpaid therapist advisor to Koya Medical.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}